Clinical Trials Directory

Trials / Completed

CompletedNCT03689088

Sensing Contact Lens-based Device for 24-hour Monitoring of Intraocular Pressure

A Prospective Pilot Study Investigating the Use of a Sensing Contact Lens-based Device for 24-hour Monitoring of Intraocular Pressure in Healthy Subjects and Patients With Open Angle Glaucoma

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
9 (actual)
Sponsor
Sensimed AG · Industry
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Glaucoma is characterized by irreversible vision loss through the progressive death of optic nerve fibers unless timely diagnosis and adequate treatment are provided. Medical therapy is aimed at lowering intraocular pressure (IOP) below a clinically determined target level in order to prevent or slow glaucoma progression. IOP is known to vary with the time of day as well as with daily activities. The current way of assessing nycthemeral IOP fluctuation is to perform repeated discrete tonometry measurements, allowing only snapshot and non-continuous measurements once per hour in the best cases. The procedure is cumbersome, expensive, inconvenient (disturbed sleep cycle as patient is awoken for nocturnal/sleep period measurements) and may not detect crucial IOP values in time. Sensimed AG has developed a new contact lens (CL)-based device intended to continuously measure IOP over 24 hours. The objective of this study is to investigate the use of device for 24-hour IOP monitoring in healthy subjects and glaucoma patients.

Conditions

Interventions

TypeNameDescription
DEVICEGoldfishGoldfish will be placed in the eye for 24h monitoring
DEVICETonometryFellow eye will be measured by tonometry

Timeline

Start date
2018-05-22
Primary completion
2018-07-04
Completion
2018-09-06
First posted
2018-09-28
Last updated
2018-12-04

Locations

1 site across 1 country: Poland

Source: ClinicalTrials.gov record NCT03689088. Inclusion in this directory is not an endorsement.